Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Bioluminescent imaging of melanoma in live mice.

Craft N, Bruhn KW, Nguyen BD, Prins R, Liau LM, Collisson EA, De A, Kolodney MS, Gambhir SS, Miller JF.

J Invest Dermatol. 2005 Jul;125(1):159-65.

2.

Microimaging characterization of a B16-F10 melanoma metastasis mouse model.

Winkelmann CT, Figueroa SD, Rold TL, Volkert WA, Hoffman TJ.

Mol Imaging. 2006 Apr-Jun;5(2):105-14.

3.

Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis.

Jenkins DE, Oei Y, Hornig YS, Yu SF, Dusich J, Purchio T, Contag PR.

Clin Exp Metastasis. 2003;20(8):733-44.

PMID:
14713107
4.

A clinically relevant, syngeneic model of spontaneous, highly metastatic B16 mouse melanoma.

Bobek V, Kolostova K, Pinterova D, Kacprzak G, Adamiak J, Kolodziej J, Boubelik M, Kubecova M, Hoffman RM.

Anticancer Res. 2010 Dec;30(12):4799-803.

PMID:
21187455
5.

Pathophysiological characteristics of melanoma in-transit metastasis in a lymphedema mouse model.

Oashi K, Furukawa H, Nishihara H, Ozaki M, Oyama A, Funayama E, Hayashi T, Kuge Y, Yamamoto Y.

J Invest Dermatol. 2013 Feb;133(2):537-44. doi: 10.1038/jid.2012.274. Epub 2012 Sep 6.

6.

Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccine.

Shrayer D, Bogaars H, Hearing VJ, Maizel A, Wanebo H.

Cancer Immunol Immunother. 1995 May;40(5):277-82.

PMID:
7600558
7.

Metastatic dissemination of B16 melanoma: pattern and sequence of metastasis.

Alterman AL, Fornabaio DM, Stackpole CW.

J Natl Cancer Inst. 1985 Oct;75(4):691-702.

PMID:
3862901
8.

Genetically fluorescent melanoma bone and organ metastasis models.

Yang M, Jiang P, An Z, Baranov E, Li L, Hasegawa S, Al-Tuwaijri M, Chishima T, Shimada H, Moossa AR, Hoffman RM.

Clin Cancer Res. 1999 Nov;5(11):3549-59.

9.

Central nervous system tumor immunity generated by a recombinant listeria monocytogenes vaccine targeting tyrosinase related protein-2 and real-time imaging of intracranial tumor burden.

Prins RM, Bruhn KW, Craft N, Lin JW, Kim CH, Odesa SK, Miller JF, Liau LM.

Neurosurgery. 2006 Jan;58(1):169-78; discussion 169-78.

PMID:
16385341
10.

Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases.

Yang M, Baranov E, Jiang P, Sun FX, Li XM, Li L, Hasegawa S, Bouvet M, Al-Tuwaijri M, Chishima T, Shimada H, Moossa AR, Penman S, Hoffman RM.

Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1206-11.

11.

Development of a preclinical model of spontaneous human melanoma central nervous system metastasis.

Cruz-Munoz W, Man S, Xu P, Kerbel RS.

Cancer Res. 2008 Jun 15;68(12):4500-5. doi: 10.1158/0008-5472.CAN-08-0041.

12.
13.

Syngeneic murine metastasis models: B16 melanoma.

Giavazzi R, Decio A.

Methods Mol Biol. 2014;1070:131-40. doi: 10.1007/978-1-4614-8244-4_10.

PMID:
24092437
14.

In vitro and in vivo effect of IFNalpha on B16F10 melanoma in two models: subcutaneous (C57BL6J mice) and lung metastasis (Swiss mice).

Martínez Conesa C, Alvarez Sánchez N, Vicente Ortega V, García Reverte J, Pascual Carpe F, Campos Aranda M.

Biomed Pharmacother. 2009 May;63(4):305-12. doi: 10.1016/j.biopha.2008.07.092. Epub 2008 Sep 7.

PMID:
19171452
15.
16.
17.

Fusion between tumor cells enhances melanoma metastatic potential.

Mi R, Pan C, Bian X, Song L, Tian W, Cao F, Yin J, Peng H, Ma J.

J Cancer Res Clin Oncol. 2012 Oct;138(10):1651-8. Epub 2012 May 24.

PMID:
22622656
18.

Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model.

Nakamura K, Yoshikawa N, Yamaguchi Y, Kagota S, Shinozuka K, Kunitomo M.

Life Sci. 2002 Jan 4;70(7):791-8.

PMID:
11833741
19.

Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation.

McCray AN, Ugen KE, Muthumani K, Kim JJ, Weiner DB, Heller R.

Mol Ther. 2006 Nov;14(5):647-55. Epub 2006 Sep 1.

PMID:
16950655
20.

Therapeutic efficacy of antigen-specific vaccination and toll-like receptor stimulation against established transplanted and autochthonous melanoma in mice.

Tormo D, Ferrer A, Bosch P, Gaffal E, Basner-Tschakarjan E, Wenzel J, Tüting T.

Cancer Res. 2006 May 15;66(10):5427-35.

Items per page

Supplemental Content

Write to the Help Desk